Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain ...

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

BTIG’s assessment suggested the company leveraged favorable industry trends and gained market share as it heads into earnings ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ('Gain”, or the 'Company”), a clinical-stage biotechnology company leading the ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global ...

BTIG analyst Andre Madrid raised the firm’s price target on Northrop Grumman (NOC) to $630 from $575 and keeps a Buy rating on the shares.

To schedule a one-on-one meeting with management, please reach out to your BTIG representative.

Detailed price information for Domino's Pizza Inc (DPZ-Q) from The Globe and Mail including charting and trades.

BTIG’s Tim Chiang believes the company is steadily progressing with these key programs. The analyst said, “We believe SRPT is making progress on the gene therapy manufacturing front, ...

BTIG made the claim in a lawsuit filed late Monday in California state court and seeks at least $200 million in damages. Have a confidential tip for our reporters? Get in Touch.